An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens - Sobas, M; Montesinos, P; Boluda, B; Sanz, MA; Chillón, M; Bernal, T; Vellenga, E; Nomdedeu, J; González-Campos, J; Holowiecka, A; Esteve, J; Bergua, J; et al. (LEUKEMIA & LYMPHOMA, 2019)